Back to GEN Stock Lookup

Genon Energy (GEN) – Company Press Releases

Apr 27, 2015 10:26 AM Genmab Announces Phase III Study of Arzerra(r) Met Primary Endpoint of Improved Progression-Free Survival in Patients with Relapsed CLL
Apr 17, 2015 11:42 AM Genesis HealthCare To Release First Quarter 2015 Results On May 7, 2015
Apr 16, 2015 09:46 AM Genmab Achieves USD 10 Million Milestone in Daratumumab Collaboration with Janssen
Mar 31, 2015 06:14 PM GeneNews Announces Q4 and Full Year 2014 Financial Results
Mar 31, 2015 06:14 PM GeneNews Announces Q4 and Full Year 2014 Financial Results
Mar 26, 2015 02:09 PM Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to two Board Members and Grant of Warrants to Employees in Genmab
Mar 18, 2015 10:14 AM Genmab Acquires Antibody Assets from iDD Biotech
Mar 16, 2015 06:36 AM Genmab Retains Partial Rights for HuMax-TAC-ADC - Will Not Exercise Co-development Right
Mar 11, 2015 01:16 PM Capital Increase in Genmab as a Result of Employee Warrant Exercise and Projection of Improved Cash Position at the End of 2015
Mar 9, 2015 10:44 AM Genesis HealthCare to Present at the Barclays Global Healthcare Conference on March 11, 2015
Mar 4, 2015 03:25 PM Genesis HealthCare Raised $250,000 For Alzheimer's Association Walk To End Alzheimer's®
Mar 2, 2015 11:07 AM Genmab 2014 Annual Report
Mar 2, 2015 01:48 AM Genmab Announces That Agreement to Transfer Ofatumumab Collaboration to Novartis is Now Effective
Feb 19, 2015 07:05 PM Genesis Healthcare Reports Fiscal Year End 2014 Results
Feb 19, 2015 09:33 AM Genmab Enters Commercial DuoBody Technology Agreement with BioNovion in the Field of Immuno-Oncology
Feb 17, 2015 12:31 PM GE Capital Leads $550 Million Line of Credit for Genesis Healthcare, Inc.
Feb 16, 2015 11:03 AM Genesis Healthcare To Release Year End And Fourth Quarter 2014 Results On February 19, 2015
Feb 4, 2015 05:58 PM Major Shareholder Announcement
Feb 4, 2015 07:05 AM Fourth Quarter and Full Year 2014 Net Sales Figures for Arzerra (ofatumumab)
Feb 3, 2015 12:08 PM Genmab Announces Preliminary Results in Phase II Study of Daratumumab in Double Refractory Multiple Myeloma
Feb 3, 2015 08:00 AM GeneNews Provides IDL Progress Update
Feb 3, 2015 07:26 AM GeneNews Announces Exercise of Warrants
Feb 3, 2015 07:26 AM GeneNews Announces Exercise of Warrants
Feb 2, 2015 01:37 PM Genesis Healthcare Combines With Skilled Healthcare Group, Inc.

Back to GEN Stock Lookup